Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 2,70€ (−11,48%). La mediana è 2,49€ (−18,36%).
| Acquista |
3 |
| Mantieni |
9 |
| Vendi |
3 |
Notizie Vai al feed delle notizie
Cronos Group hits 52-week high after strong Q2 results
The Cronos Group share rose to a 52-week high of $3.44, with a market capitalization of $1.25 billion and year-to-date performance of 25.86%. InvestingPro points to an overvaluation versus fair value. Cronos beat expectations in Q2 2026 with revenue of $53 million (expectation $44.73 million), adjusted EPS of $0.09 (expectation $0.01), gross profit of $28.5 million and adjusted EBITDA of $13.1 million; cash and investments amounted to $827 million, and $60 million in share buybacks were reported. » Altro su de.investing.com
Cronos shares rise after Q2 results significantly beat expectations
Cronos reported Q2 EPS of $0.09 (consensus $0.01) and revenue of $53.0 million versus expected $44.73 million. The company reported record net revenue, gross profit and adjusted EBITDA, organic revenue growth of 51% and record sales in Israel, Canada and Germany. Cronos repurchased a total of 12.3 million shares in H1 2026. The strong company-specific metrics pushed the stock sharply higher in pre-market trading and brought it closer to its 52-week high. » Altro su de.investing.com
Cronos Group names ATB Capital Markets as broker for share buyback program
Cronos Group has appointed ATB Capital Markets Corp. (ATB Cormark) as broker for share repurchases on the Toronto Stock Exchange and other Canadian trading systems, replacing Virtu Canada Corp. The company gave no details on the reasons, size or timing of the buyback program. Cronos has most recently pursued an aggressive buyback strategy, which coincided with a 49% share price increase last year; market capitalization is around USD 1.04 billion. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 61,86M | 117,93% |
| Utile lordo | 24,93M | 102,58% |
| Utile netto | 28,11M | 183,44% |
| EBITDA | 31,63M | 10.629,72% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 1,14Md€ |
Numero di azioni | 373,66M |
Massimo/minimo a 52 settimane | 3,07€ - 1,96€ |
| Dividendi | No |
Beta | 1,24 |
Rapporto P/E | 18,99 |
Rapporto PEG | 0,00 |
Rapporto P/B | 1,25 |
Rapporto P/S | 7,44 |
Profilo aziendale
Die Cronos Group Inc. ist als Cannabinoid-Unternehmen tätig. Es produziert, vermarktet und vertreibt aus Hanf gewonnene Nahrungsergänzungsmittel und kosmetische Produkte über E-Commerce-, Einzelhandels- und Gaststättenpartnerkanäle unter den Marken Lord Jones und Happy Dance in den Vereinigten Staaten. Das Unternehmen befasst sich auch mit dem Anbau, der Herstellung und der Vermarktung von Cannabis und Cannabisprodukten für den medizinischen Markt und den Markt für den Gebrauch durch Erwachsene. Es verkauft Cannabis und Cannabisprodukte, darunter getrocknetes Cannabis, Pre-Rolls, Esswaren, Konzentrate und Cannabisextrakte über Großhandels- und Direktvertriebskanäle unter seiner Wellness-Plattform PEACE NATURALS und ist unter der Marke Spinach für den Gebrauch durch Erwachsene tätig. Das Unternehmen exportiert auch getrocknetes Cannabis und Cannabisöle nach Deutschland, Israel und Australien. Die Cronos Group Inc. wurde im Jahr 2012 gegründet und hat ihren Sitz in Toronto, Kanada.
| Nome | Cronos |
| CEO | Michael Ryan Gorenstein |
| Sede centrale | Stayner,
on Canada |
| Sito web | |
| Settore | Sanità |
| Industria | Fornitori e servizi sanitari |
| Quotazione in borsa | 27/02/2018 |
| Dipendenti | 610 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NASDAQ | CRON |
Toronto Stock Exchange | CRON.TO |
Frankfurt | 7CI.F |
Düsseldorf | 7CI.DU |
München | 7CI.MU |
Scopri gli asset
Gli azionisti di Cronos investono anche nei seguenti asset
